Journal article · 2019
Patient preferences for maintenance PARP therapy in ovarian cancer treatment.
Journal of Clinical Oncology, 37(15_suppl), 5558 · Published 20 May 2019 · DOI 10.1200/jco.2019.37.15_suppl.5558
In brief
“Patient preferences for maintenance PARP therapy in ovarian cancer treatment.” is a 2019 journal article by Laura Jean Havrilesky and 7 co-authors, published in Journal of Clinical Oncology. OpenAlex counts 0 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- Authors
- 8
Abstract
5558 Background: Maintenance therapy with PARP inhibitors has become prevalent in treating ovarian cancer. However, the preferences of women with ovarian cancer regarding the risks, side effects and benefits afforded by maintenance therapies are largely unstudied. Methods: A discrete choice experiment was designed to elicit the preferences of women with ovarian cancer regarding 6 attributes… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Havrilesky, L. J., Lim, S. L., Yang, J., Lorenzo, A., Ehrisman, J. A., Secord, A. A., Johnson, R., & Reed, S. D. (2019). Patient preferences for maintenance PARP therapy in ovarian cancer treatment. Journal of Clinical Oncology, 37(15_suppl), 5558. https://doi.org/10.1200/jco.2019.37.15_suppl.5558
MLA 9
Havrilesky, Laura Jean, et al. “Patient preferences for maintenance PARP therapy in ovarian cancer treatment.” Journal of Clinical Oncology, vol. 37, no. 15_suppl, 2019, p. 5558. https://doi.org/10.1200/jco.2019.37.15_suppl.5558.
Chicago
Havrilesky, Laura Jean, Stephanie L. Lim, Jui‐Chen Yang, Amelia Lorenzo, Jessie A. Ehrisman, Angeles Alvarez Secord, Reed Johnson, and Shelby D. Reed. 2019. “Patient preferences for maintenance PARP therapy in ovarian cancer treatment.” Journal of Clinical Oncology 37 (15_suppl): 5558. https://doi.org/10.1200/jco.2019.37.15_suppl.5558.
Harvard
Havrilesky, L. J. et al. (2019) ‘Patient preferences for maintenance PARP therapy in ovarian cancer treatment.’, Journal of Clinical Oncology, 37(15_suppl), p. 5558. doi:10.1200/jco.2019.37.15_suppl.5558.
IEEE
L. J. Havrilesky et al., “Patient preferences for maintenance PARP therapy in ovarian cancer treatment.,” Journal of Clinical Oncology, vol. 37, no. 15_suppl, p. 5558, 2019, doi: 10.1200/jco.2019.37.15_suppl.5558.
BibTeX
@article{havrilesky2019patient,
title = {{Patient preferences for maintenance PARP therapy in ovarian cancer treatment.}},
author = {Havrilesky, Laura Jean and Lim, Stephanie L. and Yang, Jui‐Chen and Lorenzo, Amelia and Ehrisman, Jessie A. and Secord, Angeles Alvarez and Johnson, Reed and Reed, Shelby D.},
journal = {Journal of Clinical Oncology},
year = {2019},
volume = {37},
number = {15_suppl},
pages = {5558},
doi = {10.1200/jco.2019.37.15_suppl.5558},
url = {https://doi.org/10.1200/jco.2019.37.15_suppl.5558}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- ovarian cancer
- PARP inhibitors
- maintenance therapy
- patient preferences
- discrete choice experiment
- progression-free survival
- overall survival
- out-of-pocket costs
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Havrilesky, L. J., Lim, S. L., Yang, J., Lorenzo, A., Ehrisman, J. A., Secord, A. A., Johnson, R., & Reed, S. D. (2019). Patient preferences for maintenance PARP therapy in ovarian cancer treatment. Journal of Clinical Oncology, 37(15_suppl), 5558. https://doi.org/10.1200/jco.2019.37.15_suppl.5558
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Laura Jean Havrilesky, Stephanie L. Lim, Jui‐Chen Yang, Amelia Lorenzo, Jessie A. Ehrisman, Angeles Alvarez Secord, Reed Johnson, Shelby D. Reed.
What is the DOI of this paper?
10.1200/jco.2019.37.15_suppl.5558, permanently at https://doi.org/10.1200/jco.2019.37.15_suppl.5558. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.